Breaking News: Moderna and the U.S. are in a patent dispute over credit for a crucial component of its Covid vaccine. The company's patent application names several employees as the sole inventors of the component and excludes three government scientists. https://t.co/RLlESMFPfY pic.twitter.com/BLaKGVVHS2
— The New York Times (@nytimes) November 9, 2021
